Data / Research funding / New York / Halomine, Inc.
Halomine, Inc.: 5 NIH awards ($4M), fiscal years 2021 to 2026
Halomine, Inc. in Ithaca, NY is funded under 5 NIH awards ($4M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- FT1LJN4UPKJ3
- State
- New York
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Novel, low corrosion, bio-compatible disinfectant with biofilm and residual efficacy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,735,315 | August 5, 2020 | August 31, 2027 | NKEMNGONG, CARINE | reporter.nih.gov |
| Novel, bio-inspired chloramine for infection eradication in chronic wounds | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $348,150 | September 15, 2025 | September 14, 2026 | HEIN, MARC D. | reporter.nih.gov |
| Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $325,001 | June 5, 2023 | May 31, 2025 | OZKAN, EKREM | reporter.nih.gov |
| Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $299,435 | August 1, 2025 | July 31, 2026 | HEIN, MARC D. | reporter.nih.gov |
| Novel Polymer Additives for Infection Control Intravenous Catheters | NIH | National Heart, Lung, and Blood Institute | 2024 | $295,203 | July 1, 2024 | June 30, 2025 | OZKAN, EKREM | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3 | $1,639,393 | 0 | $0 |
| 2024 | 2 | $1,038,710 | 0 | $0 |
| 2023 | 2 | $1,325,001 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) | RFA-DK-27-125 | NIH | 93.847 | November 6, 2026 | Not listed | Same assistance listing 93.847 as 2 awards here |
| Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) | RFA-DK-27-112 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 2 awards here |
| Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) | RFA-DK-27-139 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 2 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 2 awards here |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) | RFA-DK-27-122 | NIH | 93.847 | November 17, 2026 | Not listed | Same assistance listing 93.847 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.847 | December 4, 2026 | Not listed | Same assistance listing 93.847 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.847 | January 5, 2027 | Not listed | Same assistance listing 93.847 as 2 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.847 | January 15, 2027 | $350,000 | Same assistance listing 93.847 as 2 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Diabetes Research Centers (P30 Clinical Trial Optional) | RFA-DK-26-310 | NIH | 93.847 | January 27, 2027 | $1 million | Same assistance listing 93.847 as 2 awards here |
| NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional) | RFA-DK-28-114 | NIH | 93.847 | January 28, 2027 | Not listed | Same assistance listing 93.847 as 2 awards here |
Topics of its NIH awards
- Bioengineering
- Infectious Diseases
- Antimicrobial Resistance
- Emerging Infectious Diseases
- Patient Safety
- Prevention
- Biodefense and Related Countermeasures
- Translational Research
- Urologic Diseases
- Hematology
- Biotechnology
- Diabetes
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.